Typicality: | 0.462 |
Saliency: | 0.308 |
in patients | 5 | other |
directly | 4 | manner |
most significantly | 2 | manner |
expression → be correlated with → tumor progression | 5 |
expression → be associated with → tumor progression | 4 |
expression → contribute to → tumor progression | 4 |
expression → be associated with → cancer progression | 4 |
negative | neutral | positive |
0.465 | 0.478 | 0.057 |
Raw frequency | 17 |
Normalized frequency | 0.308 |
Modifier score | 0.750 |
Perplexity | 209.785 |